Sintx Technologies (SINT) EBITDA Margin (2013 - 2026)
Sintx Technologies' (SINT) quarterly EBITDA Margin came in at 843.95% in Q1 2026, down 19815.0% year-on-year from N/an in Q1 2025, and down 5.58% quarter-over-quarter from 799.31% in Q4 2025.
Sintx Technologies (SINT) EBITDA Margin (2013 - 2026) Analysis & Trends
Sintx Technologies' EBITDA Margin history runs 14 years deep, the most recent figure standing at 843.95% for Q1 2026.
- On a quarterly basis, EBITDA Margin fell 19815.0% year-over-year to 843.95% in Q1 2026; TTM through Mar 2026 was 1121.96%, a 60686.0% decrease from a year earlier, with the FY2025 full-year figure at 1053.14%, down 56658.0% from the prior year.
- EBITDA Margin slipped to 843.95% in Q1 2026 per SINT's latest filing, from 799.31% in the prior quarter.
- Across five years, EBITDA Margin topped out at 301.88% in Q4 2023 and bottomed at 2232.56% in Q1 2022.
- The 5-year median for EBITDA Margin is 659.93% (2023), against an average of 833.56%.
- Across the five-year window, EBITDA Margin soared 157263 bps in 2023 and tumbled 144942 bps in 2025, its largest moves.
- Year by year, EBITDA Margin stood at 376.6% in 2022, then gained by 20 bps to 301.88% in 2023, then slipped by 6 bps to 319.56% in 2024, then sank by 150 bps to 799.31% in 2025, then slipped by 6 bps to 843.95% in 2026.
- Per Business Quant, the three latest SINT EBITDA Margin figures stand at 843.95% (Q1 2026), 799.31% (Q4 2025), and 1612.98% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sintx Technologies | 17,274.80 | -1.87 Mn | 144,000.00 | -843.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -843.95% |
| Dec 31, 2025 | -799.31% |
| Sep 30, 2025 | -1,612.98% |
| Jun 30, 2025 | -1,764.90% |
| Mar 31, 2025 | -645.80% |
| Dec 31, 2024 | -319.56% |
| Sep 30, 2024 | -802.00% |
| Jun 30, 2024 | -315.48% |
| Mar 31, 2024 | -465.36% |
| Dec 31, 2023 | -301.88% |
| Sep 30, 2023 | -533.04% |
| Jun 30, 2023 | -681.89% |
| Mar 31, 2023 | -659.93% |
| Dec 31, 2022 | -376.60% |
| Sep 30, 2022 | -655.63% |
| Jun 30, 2022 | -1,159.58% |
| Mar 31, 2022 | -2,232.56% |
| Dec 31, 2021 | -1,570.30% |
| Sep 30, 2021 | -1,182.01% |
| Jun 30, 2021 | -2,339.60% |